Literature DB >> 25006375

Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.

Suk-Hee Park1, Gaab-Soo Kim1.   

Abstract

We experienced a living donor liver transplantation for a 26-month-old girl with complement factor H deficiency. Complement factor H is a plasma protein that regulates the activity of the complement pathway. Complement overactivity induced by complement factor H deficiency is associated with atypical hemolytic uremic syndrome. Liver transplantation can be the proper treatment for this condition. During the liver transplantation of these patients, prevention of the complement overactivation is necessary. Minimizing complement activation, through the use of modalities such as plasma exchange before the surgery and transfusion of fresh frozen plasma throughout the entire perioperative period, may be the key for successful liver transplantation in these patients.

Entities:  

Keywords:  Complement factor H; Hemolytic-uremic syndrome; Liver transplantation

Year:  2014        PMID: 25006375      PMCID: PMC4085272          DOI: 10.4097/kjae.2014.66.6.481

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN: 2005-6419


  15 in total

Review 1.  Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

2.  Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Michele Colledan; Bruno Gridelli; Alessandro Bertani; Paola Bettinaglio; Sara Bucchioni; Aurelio Sonzogni; Ezio Bonanomi; Valter Sonzogni; Jeffrey L Platt; Norberto Perico; Marina Noris
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

3.  Genetic studies into inherited and sporadic hemolytic uremic syndrome.

Authors:  P Warwicker; T H Goodship; R L Donne; Y Pirson; A Nicholls; R M Ward; P Turnpenny; J A Goodship
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

4.  Complement activation after ischemia-reperfusion in human liver allografts: incidence and pathophysiological relevance.

Authors:  J Y Scoazec; G Borghi-Scoazec; F Durand; J Bernuau; B N Pham; J Belghiti; G Feldmann; C Degott
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

5.  Familial hemolytic uremic syndrome associated with complement factor H deficiency.

Authors:  D Landau; H Shalev; G Levy-Finer; A Polonsky; Y Segev; L Katchko
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

6.  Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.

Authors:  J M Saland; S H Emre; B L Shneider; C Benchimol; S Ames; J S Bromberg; G Remuzzi; L Strain; T H J Goodship
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

7.  Human complement factor H deficiency associated with hemolytic uremic syndrome.

Authors:  N Rougier; M D Kazatchkine; J P Rougier; V Fremeaux-Bacchi; J Blouin; G Deschenes; B Soto; V Baudouin; B Pautard; W Proesmans; E Weiss; L Weiss
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

8.  Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation.

Authors:  Mark C Bellamy; Jacqui A Gedney; Helen Buglass; Jimmy H C Gooi
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts.

Authors:  C Estaller; W Schwaeble; M Dierich; E H Weiss
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

10.  Attempted treatment of factor H deficiency by liver transplantation.

Authors:  Hae Il Cheong; Byong Sop Lee; Hee-Gyung Kang; Hyewon Hahn; Kyung-Suk Suh; Il Soo Ha; Yong Choi
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

View more
  2 in total

Review 1.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Fadi Fakhouri; Gema Ariceta; Nesrin Besbas; Martin Bitzan; Anna Bjerre; Rosanna Coppo; Francesco Emma; Sally Johnson; Diana Karpman; Daniel Landau; Craig B Langman; Anne-Laure Lapeyraque; Christoph Licht; Carla Nester; Carmine Pecoraro; Magdalena Riedl; Nicole C A J van de Kar; Johan Van de Walle; Marina Vivarelli; Véronique Frémeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2015-04-11       Impact factor: 3.714

2.  Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.

Authors:  Sejin Kim; Eujin Park; Sang Il Min; Nam Joon Yi; Jongwon Ha; Il Soo Ha; Hae Il Cheong; Hee Gyung Kang
Journal:  J Korean Med Sci       Date:  2018-01-01       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.